Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice

Cell Death Differ. 2000 Oct;7(10):911-5. doi: 10.1038/sj.cdd.4400715.

Abstract

Exposure of phosphatidylserine on the outer leaflet of the cytoplasmic membrane is an early event during apoptotic cell death and serves as a recognition signal for phagocytes. Usually the clearance of apoptotic cells does not initiate inflammation or immune response. We investigated the immune response in Balb/c mice towards apoptotic human T-cells. Animals injected with apoptotic cells showed significantly reduced humoral immune responses, especially Th1-dependent IgG2a titres, compared to controls immunised with viable cells. However, treatment of apoptotic cells with annexin V (AxV) significantly increased the humoral immune response. AxV binds with high affinity to anionic phospholipids and as a result interferes with the phosphatidylserine recognition by phagocytes. Our results indicate that AxV treatment may be used to increase the efficiency of apoptotic cell-based vaccines, e.g. some tumour vaccines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Annexin A5 / immunology*
  • Annexin A5 / pharmacology*
  • Apoptosis / immunology*
  • Cancer Vaccines / immunology
  • Female
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulin G / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Phagocytosis / drug effects
  • Phagocytosis / immunology
  • Protein Binding / immunology
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / immunology*

Substances

  • Annexin A5
  • Cancer Vaccines
  • Immunoglobulin G